-
therapeutic target for cardiometabolic diseases due to its beneficial effects, including stimulation of insulin-independent glucose uptake, enhancement of fatty acid oxidation, and improved insulin sensitivity
-
, employ novel pharmacological and viral targeting strategies, and learn advanced metabolic phenotyping techniques. The project is co-supervised by Associate Professor Camilla Scheele, who is a world leader
-
metabolic benefits and identify novel molecular targets for improving muscle health and insulin sensitivity. Principal supervisor: Associate Professor Atul Deshmukh at atul.deshmukh@sund.ku.dk Start
-
an understanding of individual cancers, their drug resistance mechanisms, and how they may be targeted. Our ultimate goal is to build the foundation for new types of stratified and individualized curative treatment